221 |
ELTROMDX |
ELTROMBOPAG 50 MG |
FILM COATED TABLET |
BOTTLE |
CHRONIC ITP IN ADULT AND CHILDREN 1 YEARS AND ABOVE, HEPATITIS C, SEVERE ANEMIA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1021/23 |
10-OCT-2023 |
09-OCT-2026 |
View |
222 |
ENASIDX |
ENASIDEBNIB 100 MG |
TABLET |
BOTTLE |
TO TREAT A CERTAIN TYPE OF ACUTE MYELOID LEUKEMIA THAT HAS WORSENED OR COME BACK AFTER TREATMENT WITH OTHER CHEMOTHERAPY MEDICATIONS |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1040/23 |
17-NOV-2023 |
16-NOV-2026 |
View |
223 |
ENASIDX |
ENASIDEBNIB 50 MG |
TABLET |
BOTTLE |
TO TREAT A CERTAIN TYPE OF ACUTE MYELOID LEUKEMIA THAT HAS WORSENED OR COME BACK AFTER TREATMENT WITH OTHER CHEMOTHERAPY MEDICATIONS |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1227/24 |
31-OCT-2024 |
30-OCT-2029 |
View |
224 |
ENGLEDX |
EMPAGLIFLOZIN 10 MG |
FILM COATED TABLET |
BOTTLE |
AS AB ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULT WITH DIABETE MELLITUS TYPE 2 |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1366/25 |
17-JUN-2025 |
16-JUN-2030 |
View |
225 |
ENGLEDX |
EMPAGLIFLOZIN 25 MG |
FILM COATED TABLET |
BOTTLE |
AS AB ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULT WITH DIABETE MELLITUS TYPE 2 |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1364/25 |
17-JUN-2025 |
16-JUN-2030 |
View |
226 |
ENTREDX |
ENTRECTINIB 200 MG |
CAPSULE |
BOTTLE |
TO TREAT A CERTAIN TYPE OF NON SMALL CELL LUNG CANCER IN ADULTS THAT HAS SPREAD TO OTHER PARTS OF THE BODY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1039/23 |
17-NOV-2023 |
16-NOV-2026 |
View |
227 |
ERDADX |
ERDAFITINIB 4 MG |
FILM COATED TABLET |
BOTTLE |
TO TREAT CERTAIN TYPES OF UROTHELIAL CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0992/23 |
31-JUL-2023 |
30-JUL-2026 |
View |
228 |
FEBUSODX |
FEBUXOSTAT 40 MG |
TABLET |
BOTTLE |
FOR THE CHRONIC MANAGEMENT OF HYPERURICEMIA IN ADULT PATIENTS WITH GOUT WHO HAVE AN INADEQUAT RESPONSE TO A MAXIMALLY TITRATED DOSE OF ALLOPURINOL, WHO ARE INTOLERANT TO ALLOPURINOL OR FOR WHOM TREATMENT WITH ALLOPURINOL IS NOT ADVISABLE |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1199/24 |
03-OCT-2024 |
02-OCT-2029 |
View |
229 |
GILLIDX |
GILTERITINIB 40 MG |
FILM COATED TABLET |
BOTTLE |
TREAT ADULTS WITH ACUTE MYELOID LEUKAEMIA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 0966/23 |
28-APR-2023 |
27-APR-2026 |
View |
230 |
ILUDX |
IBRUTINIB 140 MG |
CAPSULE |
BOTTLE |
TO TREAT WITH MANTLE CELL LYMPHOMA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0991/23 |
31-JUL-2023 |
30-JUL-2026 |
View |